Waters Corporation (WAT) is a Medical - Diagnostics & Research company in the Healthcare sector, currently trading at $330.98. It has a SharesGrow Score of 67/100, indicating a above average investment profile with 4 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of WAT = $290.52 (-12.2% from the current price, the stock appears overvalued). Analyst consensus target is WAT = $401 (+21.2% upside).
Valuation: WAT trades at a trailing Price-to-Earnings (P/E) of 29 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 2.18.
Financials: revenue is $3.2B, +2.2%/yr average growth. Net income is $643M, growing at -3.1%/yr. Net profit margin is 20.3% (strong). Gross margin is 57.8% (-0.2 pp trend).
Balance sheet: total debt is $1.4B against $2.6B equity (Debt-to-Equity (D/E) ratio 0.55, moderate). Debt-to-assets is 27.7%. Total assets: $5.1B.
Analyst outlook: 10 / 34 analysts rate WAT as buy (29%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 54/100 (Partial), Growth 30/100 (Fail), Past 100/100 (Pass), Health 75/100 (Pass), Moat 76/100 (Pass), Future 46/100 (Partial), Income 85/100 (Pass).
